Cited by 229Bacterial Cancer TherapyAmino Acid Enzymes and MetabolismCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges

Open access

Phillips, Melissa M., Sheaff, Michael T., Szlosarek, Peter W.·2013·Cancer Research and Treatment

DOI 10.4143/crt.2013.45.4.251PMC PMC3893322

Open this paper in CoChat — free account Open PDF

Abstract

Arginine deprivation is a novel antimetabolite strategy for the treatment of arginine-dependent cancers that exploits differential expression and regulation of key urea cycle enzymes. Several studies have focused on inactivation of argininosuccinate synthetase 1 (ASS1) in a range of malignancies, including melanoma, hepatocellular carcinoma (HCC), mesothelial and urological cancers, sarcomas, and lymphomas. Epigenetic silencing has been identified as a key mechanism for loss of the tumor suppressor role of ASS1 leading to tumoral dependence on exogenous arginine. More recently, dysregulation of argininosuccinate lyase has been documented in a subset of arginine auxotrophic glioblastoma multiforme, HCC and in fumarate hydratase-mutant renal cancers. Clinical trials of several arginine depletors are ongoing, including pegylated arginine deiminase (ADI-PEG20, Polaris Group) and bioengineered forms of human arginase. ADI-PEG20 is furthest along the path of clinical development from combinatorial phase 1 to phase 3 trials and is described in more detail. The challenge will be to identify tumors sensitive to drugs such as ADI-PEG20 and integrate these agents into multimodality drug regimens using imaging and tissue/fluid-based biomarkers as predictors of response. Lastly, resistance pathways to arginine deprivation require further study to optimize arginine-targeted therapies in the oncology clinic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.4143/crt.2013.45.4.251

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683
Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry
Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., & Mann, M. (1996) · Nature · doi:10.1038/379466a0 · Cited by 1,674
Targeting cancer metabolism: a therapeutic window opens
Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,443
Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion
Zea, A. H., Rodrı́guez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D. F., Quiceno, D. G., Youmans, A. J., O’Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 852
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485
Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects
Broome, J. D. (1961) · Nature · doi:10.1038/1911114a0 · Cited by 461
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441
Self-citation
EVIDENCE THAT THE L -ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS
Broome, J. D. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.118.1.99 · Cited by 349
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
Iwamoto, S., Mihara, K., Downing, J. R., Pui, C., & Campana, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30235 · Cited by 336
Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle
Husson, A., Brasse‐Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03559.x · Cited by 335
Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe-Goulden, J., Jung, J. U., Gandour‐Edwards, R. F., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 321
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers
Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2004) · Cancer · doi:10.1002/cncr.20057 · Cited by 317
Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315
Pegylated Recombinant Human Arginase (rhArg-peg5,000mw) Inhibits the In vitro and In vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion
Cheng, P., Lam, T. L., Lam, W.-M., Tsui, S. M., Cheng, A. W. M., Lo, W. H., & Leung, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 280
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies
Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250
Asparagine Synthetase Chemotherapy
Richards, N. G. J., & Kilberg, M. S. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142520 · Cited by 244
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Activation of Ras/PI3K/ERK Pathway Induces c-Myc Stabilization to Upregulate Argininosuccinate Synthetase, Leading to Arginine Deiminase Resistance in Melanoma Cells
Tsai, W.-B., Aiba, I., Long, Y., Lin, H., Feun, L. G., Savaraj, N., & Kuo, M. T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3605 · Cited by 235
Requirement of argininosuccinate lyase for systemic nitric oxide production
Erez, A., Nagamani, S. C. S., Shchelochkov, O. A., Premkumar, M. H., Campeau, P. M., Chen, Y., Garg, H. K., Li, L., Mian, A., Bertin, T. K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2544 · Cited by 233
Adipocytes Cause Leukemia Cell Resistance to L -Asparaginase via Release of Glutamine
Ehsanipour, E. A., Sheng, X., Behan, J. W., Wang, X., Butturini, A. M., Avramis, V. I., & Mittelman, S. D. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4402 · Cited by 189
Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma
Glazer, E. S., Piccirillo, M., Albino, V., Giacomo, R. D., Palaia, R., Mastro, A. A., Beneduce, G., Castello, G., Rosa, V. D., Petrillo, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7765 · Cited by 187
In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion
Szlosarek, P. W., Klampatsa, A., Pallaska, A., Sheaff, M. T., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P. C., Rudd, R., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181
Self-citation
Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells
Scott, L., Lamb, J., Smith, S. H., & Wheatley, D. N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1353 · Cited by 176
Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
Takezawa, K., Okamoto, I., Okamoto, W., Takeda, M., Sakai, K., Tsukioka, S., Kuwata, K., Yamaguchi, H., Nishio, K., & Nakagawa, K. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.129 · Cited by 170
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
Syed, N., Langer, J., Janczar, K., Singh, P., Nigro, C. L., Lattanzio, L., Coley, H. M., Hatzimichael, E. C., Bomalaski, J. S., Szlosarek, P. W., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.197 · Cited by 167
Self-citation
Molecular profiling of platinum resistant ovarian cancer
Helleman, J., Jansen, M. P. H. M., Span, P. N., van Staveren, I. L., Massuger, L. F. A. G., Gelder, M. E. M., Sweep, F. C. G. J., Ewing, P. C., van der Burg, M. E. L., Stoter, G., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21599 · Cited by 165
Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity
Offman, M. N., Król, M., Patel, N. R., Krishnan, S., Liu, J., Saha, V., & Bates, P. A. (2010) · Blood · doi:10.1182/blood-2010-07-298422 · Cited by 164
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
Yang, T., Lu, S., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T., Chen, S.-C., Wang, J., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 160
Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy
Righi, L., Papotti, M. G., Ceppi, P., Billè, A., Bacillo, E., Molinaro, L., Ruffini, E., Scagliotti, G. V., & Selvaggi, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9275 · Cited by 159
ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance
Huang, H.-Y., Wu, W.-R., Wang, Y.-H., Wang, J., Fang, F.-M., Tsai, J.-W., Li, S.-H., Hung, H.-C., Yu, S.-C., Lan, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2641 · Cited by 154
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153
Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging
Allen, M. D., Luong, P., Hudson, C. D., Leyton, J., Delage, B., Ghazaly, E. A., Cutts, R. J., Yuan, M., Syed, N., Nigro, C. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1702 · Cited by 152
Self-citation
Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression
Sigmond, J., Backus, H. H. J., Wouters, D., Temmink, O. H., Jansen, G., & Peters, G. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00287-9 · Cited by 147
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9862-2 · Cited by 146
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis
Delage, B., Luong, P., Maharaj, L., Ó’Riain, C., Syed, N., Crook, T., Hatzimichael, E. C., Papoudou‐Bai, A., Mitchell, T. J., Whittaker, S. J., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.83 · Cited by 144
Self-citation
Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1α/Sp4
Tsai, W.-B., Aiba, I., Lee, S.-Y., Feun, L. G., Savaraj, N., & Kuo, M. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0794 · Cited by 143
Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis
Gong, H., Zölzer, F., Recklinghausen, G. V., Havers, W., & Schweigerer, L. (2000) · Leukemia · doi:10.1038/sj.leu.2401763 · Cited by 138
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133
Self-citation
The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia
Truelove, E., Fielding, A. K., & Hunt, B. J. (2012) · Leukemia · doi:10.1038/leu.2012.290 · Cited by 133
Arginine stimulates intestinal cell migration through a focal adhesion kinase dependent mechanism
Rhoads, J. M., Chen, W., Gookin, J. L., Wu, G., Fu, Q., Blikslager, A. T., Rippe, R. A., Argenzio, R. A., Cance, W. G., Weaver, E. M., et al. (2004) · Gut · doi:10.1136/gut.2003.027540 · Cited by 126
Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy
Sikora, A. G., Gelbard, A. H., Davies, M. A., Sano, D., Ekmekçioglu, S., Kwon, J., Hailemichael, Y., Jayaraman, P., Myers, J. N., Grimm, E. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3123 · Cited by 125
In vivo anti‐tumor activity of arginine deiminase purified from Mycoplasma arginini
Takaku, H., Takase, M., Abe, S., Hayashi, H., & Miyazaki, K. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510213 · Cited by 123
Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 122
Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction
Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0302 · Cited by 121
Pegylated arginine deiminase: a novel anticancer enzyme agent
Feun, L. G., & Savaraj, N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.815 · Cited by 118
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase
Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 117
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113
Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma
Savaraj, N., You, M., Wu, C., Wangpaichitr, M., Kuo, M. T., & Feun, L. G. (2010) · Current Molecular Medicine · doi:10.2174/156652410791316995 · Cited by 110
Pegylated arginase I: a potential therapeutic approach in T-ALL
Hernandez, C. P., Morrow, K. D., Lopez-Barcons, L. A., Zabaleta, J., Sierra, R. A., Velasco, C., COLE, J. T., & Rodrı́guez, P. C. (2010) · Blood · doi:10.1182/blood-2009-12-258822 · Cited by 104
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
Yau, T. C. C., Cheng, P. N.-M., Chan, P., Chan, W., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., & Poon, R. T. P. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9807-9 · Cited by 104
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
Zheng, L., MacKenzie, E. D., Karim, S. A., Hedley, A., Blyth, K., Kalna, G., Watson, D. G., Szlosarek, P., Frezza, C., & Gottlieb, E. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-12 · Cited by 103
Self-citation
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
Is, P., Kang, S.-W., Shin, Y.-J., Chae, K.-Y., Park, M.-O., Kim, M. Y., Wheatley, D. N., & Min, B.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601181 · Cited by 97
A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia
Adam, J., Yang, M., Bauerschmidt, C., Kitagawa, M., O’Flaherty, L., Maheswaran, P., Özkan, G., Sahgal, N., Baban, D., Kato, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.006 · Cited by 97
Arginine deiminase has multiple regulatory roles in the biology ofGiardia lamblia
Touz, M. C., Ropolo, A. S., Rivero, M. R., Vranych, C. V., Conrad, J. T., Svärd, S. G., & Nash, T. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.026963 · Cited by 94
Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target
Grimm, E. A., Sikora, A. G., & Ekmekçioglu, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1554 · Cited by 92
Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler, D., Kressner, U., Ragnhammar, P., Johnston, P. G., Magnusson, I., Glimelius, B. L. G., Påhlman, L., Lindmark, G. E., & Blomgren, H. (2000) · PubMed · Cited by 89
Arginine Stimulates cdx2-Transformed Intestinal Epithelial Cell Migration via a Mechanism Requiring Both Nitric Oxide and Phosphorylation of p70 S6 Kinase1,
Rhoads, J. M., Liu, Y., Niu, X., Surendran, S., & Wu, G. (2008) · Journal of Nutrition · doi:10.1093/jn/138.9.1652 · Cited by 82
Arginine Deiminase Inhibits Cell Proliferation by Arresting Cell Cycle and Inducing Apoptosis
Gong, H., Zölzer, F., Recklinghausen, G. V., Rössler, J. K., Breit, S., Havers, W., Fotsis, T., & Schweigerer, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1004 · Cited by 76
Controlling cancer by restricting arginine availability–arginine-catabolizing enzymes as anticancer agents
Wheatley, D. N. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00002 · Cited by 74
Metabolic Response to Pegylated Arginine Deiminase in Mesothelioma With Promoter Methylation of Argininosuccinate Synthetase
Szlosarek, P. W., Luong, P., Phillips, M. M., Baccarini, M., Ellis, S. M., Szyszko, T. A., Sheaff, M. T., & Avril, N. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.1784 · Cited by 74
Self-citation
TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation
You, M., Savaraj, N., Kuo, M. T., Wangpaichitr, M., Varona-Santos, J., Wu, C., Nguyen, D. M., & Feun, L. G. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1518-1 · Cited by 72
Bioengineered Human Arginase I with Enhanced Activity and Stability Controls Hepatocellular and Pancreatic Carcinoma Xenografts
Glazer, E. S., Stone, E. M., Zhu, C., Massey, K. L., Hamir, A. N., & Curley, S. A. (2011) · Translational Oncology · doi:10.1593/tlo.10265 · Cited by 67
Depletion of Dietary Arginine Inhibits Growth of Metastatic Tumor
Yeatman, T. J. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410350066010 · Cited by 67
Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase
Shen, L.-J., Lin, W.-C., Beloussow, K., & Shen, W.-C. (2003) · Cancer Letters · doi:10.1016/s030-43835(02)00693-6 · Cited by 66
Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance
Lan, J., Tai, H., Lee, S., Chen, T., Huang, H., & Li, C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1020-8 · Cited by 66
Aberrant regulation of argininosuccinate synthetase by TNF‐α in human epithelial ovarian cancer
Szlosarek, P. W., Grimshaw, M. J., Wilbanks, G. D., Hagemann, T., Wilson, J. L., Burke, F., Stamp, G., & Balkwill, F. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22666 · Cited by 61
Self-citation
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma
Melaiu, O., Cristaudo, A., Melissari, E., Russo, M. D., Bonotti, A., Bruno, R., Foddis, R., Gemignani, F., Pellegrini, S., & Landi, S. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.003 · Cited by 60
ADI, autophagy and apoptosis: Metabolic stress as a therapeutic option for prostate cancer
Kim, R. H., Bold, R. J., & Kung, H.-J. (2009) · Autophagy · doi:10.4161/auto.5.4.8252 · Cited by 56
Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells
Tanios, R. F., Bekdash, A., Kassab, E., Stone, E. M., Georgiou, G., Frankel, A. E., & Abi‐Habib, R. J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.08.007 · Cited by 55
Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: Potentiation by irradiation
Gong, H., Pöttgen, C., Stüben, G., Havers, W., Stuschke, M., & Schweigerer, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11298 · Cited by 53
Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia
Morrow, K. D., Hernandez, C. P., Raber, P. L., Valle, L. D., Wilk, A. M., Majumdar, S., Wyczechowska, D. D., Krzysztof Reiss, F., & Rodrı́guez, P. C. (2012) · Leukemia · doi:10.1038/leu.2012.247 · Cited by 50
Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation
Vynnytska‐Myronovska, B., Bobak, Y. P., Garbe, Y., Dittfeld, C., Stasyk, O. V., & Kunz‐Schughart, L. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26221 · Cited by 48
Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells
Vynnytska‐Myronovska, B., Mayevska, O. M., Kurlishchuk, Y. V., Bobak, Y. P., & Stasyk, O. V. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833e0334 · Cited by 46
The Effects of Arginine Deficiency on Lymphoma Cells
Storr, J. M., & Burton, A. F. (1974) · British Journal of Cancer · doi:10.1038/bjc.1974.112 · Cited by 44
Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?
Douer, D. (2008) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.08.004 · Cited by 42
Glutamine and arginine affect Caco-2 cell proliferation by promotion of nucleotide synthesis
Yamauchi, K., Komatsu, T., Kulkarni, A. D., Ohmori, Y., Minami, H., Ushiyama, Y., Nakayama, M., & Yamamoto, S. (2002) · Nutrition · doi:10.1016/s0899-9007(01)00788-2 · Cited by 40
Favorable remission induction rate with twice weekly doses of L-asparaginase.
Jaffe, N., Traggis, D., Das, L. M. V., Frauenberger, G., Hann, H. W., Kim, B. S., & Bishop, Y. M. M. (1973) · PubMed · Cited by 39
Recombinant Human Arginase Toxicity in Mice Is Reduced by Citrulline Supplementation
Mauldin, J., Zeinali, I., Kleypas, K., Woo, J. H., Blackwood, R. S., Jo, C.-H., Stone, E. M., Georgiou, G., & Frankel, A. E. (2012) · Translational Oncology · doi:10.1593/tlo.11262 · Cited by 38
Attenuation of Argininosuccinate Lyase Inhibits Cancer Growth via Cyclin A2 and Nitric Oxide
Huang, H.-L., Hsu, H., Shieh, S.-C., Chang, Y.-S., Chen, W.-C., Cho, C.-Y., Teng, C., Su, I., Hung, W.-C., & Lai, M.-D. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0863 · Cited by 37
Some aspects of the role of arginine and arginase in mouse carcinoma 63.
Sj, B., & Lasnitzki, I. (1947) · PubMed · Cited by 37
Amino acid regulation of mammalian gene expression in the intestine
Brasse‐Lagnel, C., Lavoinne, A., & Husson, A. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.021 · Cited by 36
The influence of arginine upon the growth rate of a transplantable tumour in the mouse
Gilroy, E. (1930) · Biochemical Journal · doi:10.1042/bj0240589 · Cited by 35
Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells
Agrawal, V., Woo, J. H., Mauldin, J., Jo, C., Stone, E. M., Georgiou, G., & Frankel, A. E. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834ae42b · Cited by 34
Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine Treatment
Braas, D., Ahler, E., Tam, B., Nathanson, D. A., Riedinger, M., Benz, M., Smith, K. B., Eilber, F. C., Witte, O. N., Tap, W. D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0197 · Cited by 32
Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma
Chow, A. K.-M., Ng, L., Li, H. S., Cheng, C. W., Lam, C. S. C., Yau, T. C. C., Cheng, P., Fan, S. T., Poon, R. T. P., & Pang, R. W. C. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912803988002 · Cited by 32
Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer
Ceppi, P., Rapa, I., Iacono, M. L., Righi, L., Giorcelli, J., Pautasso, M., Billè, A., Ardissone, F., Papotti, M. G., & Scagliotti, G. V. (2011) · International Journal of Cancer · doi:10.1002/ijc.26188 · Cited by 30
Involvement of autophagy in recombinant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells
Wang, Z., Shi, X., Li, Y., Zeng, X. L., Fan, J., Sun, Y., Xian, Z., Zhang, G., Wang, S., Hu, H., et al. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5118-0 · Cited by 30
Alternatively Activated Macrophage Possess Antitumor Cytotoxicity That Is Induced by IL-4 and Mediated by Arginase-1
Ellyard, J. I., Quah, B., Simson, L., & Parish, C. R. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181cd8746 · Cited by 29
Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy
Stone, E. M., Chantranupong, L., Gonzalez, C., O’Neal, J. F., Rani, M., Berg, C. L. V. D., & Georgiou, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.097 · Cited by 28
Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling
Fu, Y., Zhang, H., Ding, M., Li, Y., Fu, X., Yu, Z., & Meadows, G. G. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-5515-y · Cited by 27
Short-term arginine deprivation results in large-scale modulation of hepatic gene expression in both normal and tumor cells: microarray bioinformatic analysis
Leong, H. X., Simkevich, C. P., Lesieur-Brooks, A. M., Lau, B. W., Fugère, C., Sabo, E., & Thompson, N. L. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-37 · Cited by 23
Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment
Fung, K.-L., & Chi-Fung, C. G. (2013) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-2-11 · Cited by 20
Effect of Arginine Deficiency on Synthesis of DNA and Immunoglobulin Receptor of Burkitt Lymphoma Cells
Osunkoya, B. O., Adler, W. H., & Smith, R. T. (1970) · Nature · doi:10.1038/227398a0 · Cited by 18
Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma
Stelter, L., Evans, M. J., Jungbluth, A. A., ZANZONICO, P. B., Ritter, G., Ku, T. W., Rosenfeld, E., Bomalaski, J. S., Old, L. J., & Larson, S. M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092973 · Cited by 18
Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.
Stelter, L., Evans, M. J., Jungbluth, A. A., Longo, V. A., ZANZONICO, P. B., Ritter, G., Bomalaski, J. S., Old, L. J., & Larson, S. M. (2013) · PubMed · Cited by 14
Evaluation of Arginine Deiminase Treatment in Melanoma Xenografts Using 18F-FLT PET
Stelter, L., Fuchs, S., Jungbluth, A. A., Ritter, G., Longo, V. A., ZANZONICO, P. B., Raschzok, N., Sauer, I. M., Bomalaski, J. S., & Larson, S. M. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0655-6 · Cited by 13
No Child Left Behind in SDHB Testing for Paragangliomas and Pheochromocytomas
Schiffman, J. D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8695 · Cited by 13
RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
Wu, F. L., Liang, Y.-F., Chang, Y.-C., Yo, H.-H., Wei, M., & Shen, L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-25 · Cited by 9
Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer
Li, Y., Li, X., Dai, H.-P., Sun, X., Li, J., Yang, F., Gu, H., Yang, Y., Jin, Z., Chu, Y., et al. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08099.x · Cited by 7
Using pegylated arginine deiminase (ADI-PEG20) for the treatment of sarcomas that lack argininosuccinate synthesase 1 expression.
Tine, B. A. V., Bean, G. R., Boone, P. F., Tanas, M. R., Schulze, M. B., Chen, D. Y., Bomalaski, J. S., & Rubin, B. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.10526 · Cited by 3
Abstract 5382: Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma
Chow, A. K.-M., Pang, R. W. C., Chu, A. C. Y., Ng, L., & Poon, R. T. P. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-5382 · Cited by 2

Flagged first, then by citations

Sorted by citations

Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,369
Autophagy and autophagy-related pathways in cancer
Debnath, J., Gammoh, N., & Ryan, K. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00585-z · Cited by 1,506
The cancer metabolic reprogramming and immune response
Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01316-8 · Cited by 1,312
Serine and one-carbon metabolism in cancer
Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971

See all 229

Authors: Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W.
Affiliations: St Bartholomew's Hospital (GB)
Queen Mary University of London (GB)
Corresponding author: Szlosarek, Peter W.
ORCID: Sheaff, Michael T.
Szlosarek, Peter W.
Venue: Cancer Research and Treatment
Publisher: Korean Cancer Association
Published: 2013-12-31
Volume: 45
Issue: 4
Pages: 251-262
ISSN: 1598-2998 (ISSN-L)
2005-9256
DOI: 10.4143/crt.2013.45.4.251
PMC: PMC3893322
OpenAlex: W2106712645
Cited by: 229
References: 105
Citations by year: 2026: 6 · 2025: 19 · 2024: 6 · 2023: 16 · 2022: 43 · 2021: 26 · 2020: 14 · 2019: 11 · 2018: 17 · 2017: 23 · 2016: 18 · 2015: 20 · 2014: 10
FWCI: 2.39
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
creativecommons.org/licenses/by-nc/3.0/ (tdm)
Locations: Cancer Research and Treatment (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: arginine deprivation, argininosuccinate synthetase 1, argininosuccinate lyase, fumarate hydratase, arginine deiminase, ADI-PEG20, arginase, urea cycle enzymes, epigenetic silencing, melanoma, hepatocellular carcinoma, glioblastoma, renal cell carcinoma, treatment response biomarkers, drug resistance, multimodal therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks